Physician profile
Devon Cole
NPI 1710117098
$1,680.10
in general payments reported to CMS, 2019-2025
11 companies · $28.72 in 2025
The $28.72 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $630 · 2021: $28.04 · 2022: $203 · 2023: $92.32 · 2024: $235 · 2025: $28.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $839.62 | 2019-2025 | |
| Boston Scientific Corporation | $194.61 | 2023-2024 | Watchman Flx |
| Medtronic Vascular, INC. | $156.07 | 2019 | |
| La Jolla Pharmaceutical Company | $145.89 | 2019 | |
| Getinge USA Sales, LLC | $143.38 | 2019-2022 | |
| Abbott Laboratories | $67.57 | 2020-2024 | Xience Skypoint, Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $43.27 | 2024 | Xarelto |
| Abbvie INC. | $28.04 | 2021 | |
| Biosense Webster, INC. | $23.64 | 2024 | Nuvision Ice Catheter |
| Shockwave Medical, INC | $23.04 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pacira Pharmaceuticals Incorporated | $14.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.